Skip to main content

Advertisement

SpringerLink
Log in

The features of adipose-derived stem cells in patients with inflammatory bowel diseases

  • Original Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Purpose

The treatment outcomes for inflammatory bowel disease (IBD) have been improving, but the development of better therapies is needed. Stem cell therapy is promising, but little is known about the differences in adipose-derived stem cells (ADSCs) between IBD patients and healthy individuals.

Methods

ADSCs were isolated from subcutaneous adipose tissue (SAT) in IBD (Crohn’s disease, 3; ulcerative colitis, 2) and non-IBD (colorectal cancer, 5; breast cancer, 1) patients. We also analyzed the effects of tumor necrosis factor (TNF)-α on murine ADSCs.

Results

The numbers of stromal vascular fraction (SVF) cells per gram of SAT were 7.72 ± 3.03 × 105 in IBD and 8.51 ± 8.80 × 105 in non-IBD patients (p > 0.05). The proportions of ADSCs in SVF cells were 4.98 ± 2.61% in IBD and 1.02 ± 0.67% in non-IBD patients. The numbers of ADSCs per gram of SAT were 4.16 ± 2.96 × 104 in IBD and 0.88 ± 1.04 × 104 in non-IBD patients. The proportions and numbers of ADSCs were significantly higher in IBD patients than in non-IBD patients. TNF-α significantly facilitated the proliferation and motility of murine ADSCs.

Conclusion

These results showed the potential advantage of freshly isolated autologous ADSCs in IBD patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Yui S, Nakamura T, Sato T, Nemoto Y, Mizutani T, Zheng X, et al. Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr5(+) stem cell. Nat Med. 2012;18:618–23.

    Article  CAS  PubMed  Google Scholar 

  2. Rubin JP, Marra KG. Adipose stem cell therapy for soft tissue reconstruction. Lancet. 2013;382:1077–9.

    Article  PubMed  Google Scholar 

  3. Fisher SA, Brunskill SJ, Doree C, Mathur A, Taggart DP, Martin-Rendon E. Stem cell therapy for chronic ischaemic heart disease and congestive heart failure. Cochrane Database Syst Rev. 2016;12:CD007888.

    PubMed  Google Scholar 

  4. El-Badawy A, El-Badri N. Clinical efficacy of stem cell therapy for diabetes mellitus: a meta-analysis. PLoS One. 2016;11:e0151938.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Dentelli P, Barale C, Togliatto G, Trombetta A, Olgasi C, Gili M, et al. A diabetic milieu promotes OCT4 and NANOG production in human visceral-derived adipose stem cells. Diabetologia. 2013;56:173–84.

    Article  CAS  PubMed  Google Scholar 

  6. Iwen KA, Priewe A-C, Minnefeld M, Rose C, Siemers F, Rohwedel J, et al. Gluteal and abdominal subcutaneous adipose tissue depots as stroma cell source: gluteal cells display increased adipogenic and osteogenic differentiation potentials. Exp Dermatol. 2014;23:395–400.

    Article  CAS  PubMed  Google Scholar 

  7. Ohmura Y, Tanemura M, Kawaguchi N, Machida T, Tanida T, Deguchi T, et al. Combined transplantation of pancreatic islets and adipose tissue-derived stem cells enhances the survival and insulin function of islet grafts in diabetic mice. Transplantation. 2010;90:1366–73.

    Article  CAS  PubMed  Google Scholar 

  8. Zhao QJ, Yu YB, Zuo XL, Dong YY, Li YQ. Milk fat globule-epidermal growth factor 8 is decreased in intestinal epithelium of ulcerative colitis patients and thereby causes increased apoptosis and impaired wound healing. Mol Med. 2012;18:497–506.

    CAS  PubMed  Google Scholar 

  9. Lenoir N. Europe confronts the embryonic stem cell research challenge. Science. 2000;287:1425–7.

    Article  CAS  PubMed  Google Scholar 

  10. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–76.

    Article  CAS  PubMed  Google Scholar 

  11. Ohgushi H, Caplan AI. Stem cell technology and bioceramics: from cell to gene engineering. J Biomed Mater Res. 1999;48:913–27.

    Article  CAS  PubMed  Google Scholar 

  12. Al-Saqi SH, Saliem M, Asikainen S, Quezada HC, Ekblad A, Hovatta O, et al. Defined serum-free media for in vitro expansion of adipose-derived mesenchymal stem cells. Cytotherapy. 2014;16:915–26.

    Article  CAS  PubMed  Google Scholar 

  13. Anderson P, Souza-Moreira L, Morell M, Caro M, O’Valle F, Gonzalez-Rey E, et al. Adipose-derived mesenchymal stromal cells induce immunomodulatory macrophages which protect from experimental colitis and sepsis. Gut. 2013;62:1131–41.

    Article  CAS  PubMed  Google Scholar 

  14. Kilroy GE, Foster SJ, Wu X, Ruiz J, Sherwood S, Heifetz A, et al. Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors. J Cell Physiol. 2007;212:702–9.

    Article  CAS  PubMed  Google Scholar 

  15. Garcia-Olmo D, Garcia-Arranz M, Garcia LG, Cuellar ES, Blanco IF, Prianes LA, et al. Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn’s disease: a new cell-based therapy. Int J Colorectal Dis. 2003;18:451–4.

    Article  PubMed  Google Scholar 

  16. Lee WY, Park KJ, Cho YB, Yoon SN, Song KH, Kim DS, et al. Autologous adipose tissue-derived stem cells treatment demonstrated favorable and sustainable therapeutic effect for Crohn’s fistula. Stem Cells. 2013;31:2575–81.

    Article  CAS  PubMed  Google Scholar 

  17. Mizushima T, Takahashi H, Takeyama H, Naito A, Haraguchi N, Uemura M, et al. A clinical trial of autologous adipose-derived regenerative cell transplantation for a postoperative enterocutaneous fistula. Surg Today. 2016;46:835–42.

    Article  CAS  PubMed  Google Scholar 

  18. Panes J, Garcia-Olmo D, Assche GV, Colombel JF, Reinisch W, Baumgart DC. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn’s disease: a phase 3 randomised, double-blind controlled trial. Lancet. 2016;388:1281–90.

    Article  PubMed  Google Scholar 

  19. Ciccocioppo R, Bernardo ME, Sgarella A, Maccario R, Avanzini MA, Ubezio C, et al. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn’s disease. Gut. 2011;60:788–98.

    Article  PubMed  Google Scholar 

  20. Garcia-Bosch O, Ricart E, Panes J. Review article: stem cell therapies for inflammatory bowel disease—efficacy and safety. Aliment Pharmacol Ther. 2010;32:939–52.

    Article  CAS  PubMed  Google Scholar 

  21. Duijvestein M, Vos ACW, Roelofs H, Wildenberg ME, Wendrich BB, Verspaget HW, et al. Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn’s disease: results of a phase I study. Gut. 2010;59:1662–9.

    Article  PubMed  Google Scholar 

  22. Forbes GM, Sturm MJ, Leong RW, Sparrow MP, Segarajasingam D, Cummins AG, et al. A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn’s disease refractory to biologic therapy. Clin Gastroenterol Hepatol. 2014;12:64–71.

    Article  PubMed  Google Scholar 

  23. Izadpanah R, Trygg C, Patel B, Kriedt C, Dufour J, Gimble JM, et al. Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue. J Cell Biochem. 2006;99:1285–97.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Baek SJ, Kang SK, Ra JC. In vitro migration capacity of human adipose tissue-derived mesenchymal stem cells reflects their expression of receptors for chemokines and growth factors. Exp Mol Med. 2011;43:596–603.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Suga H, Eto H, Shigeura T, Inoue K, Aoi N, Kato H, et al. IFATS collection: fibroblast growth factor-2-induced hepatocyte growth factor secretion by adipose-derived stromal cells inhibits postinjury fibrogenesis through a c-Jun N-terminal kinase-dependent mechanism. Stem Cells. 2009;27:238–49.

    Article  CAS  PubMed  Google Scholar 

  26. Pallagi-Kunstár É, Farkas K, Szepes Z, Nagy F, Szűcs M, Kui R, et al. Utility of serum TNF-α, infliximab trough level, and antibody titers in inflammatory bowel disease. World J Gastroenterol. 2014;20:5031–5.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Bertin B, Desreumaux P, Dubuquoy L. Obesity, visceral fat and Crohn’s disease. Curr Opin Clin Nutr Metab Care. 2010;13:574–80.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by a Grant-in-Aid for Scientific Research.

Author information

Authors and Affiliations

  1. Department of Therapeutics for Inflammatory Bowel Diseases, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan

    Tsunekazu Mizushima

  2. Department of Surgery, Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan

    Tsunekazu Mizushima, Tadafumi Fukata, Hiroshi Takeyama, Hidekazu Takahashi, Naotsugu Haraguchi, Junichi Nishimura, Taishi Hata, Chu Matsuda, Hirofumi Yamamoto, Yuichiro Doki & Masaki Mori

Authors
  1. Tsunekazu Mizushima
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tadafumi Fukata
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hiroshi Takeyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hidekazu Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Naotsugu Haraguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Junichi Nishimura
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Taishi Hata
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Chu Matsuda
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hirofumi Yamamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Yuichiro Doki
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Masaki Mori
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tsunekazu Mizushima.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mizushima, T., Fukata, T., Takeyama, H. et al. The features of adipose-derived stem cells in patients with inflammatory bowel diseases. Surg Today 48, 352–358 (2018). https://doi.org/10.1007/s00595-017-1591-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-017-1591-x

Keywords

Search

Navigation